HYDROCORTISONE BUTYRATE

HYDROCORTISONE BUTYRATE was reported 1976 times

HYDROCORTISONE BUTYRATE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 GRANULOMA GLUTEALE INFANTUM 1 0.5000
1 HEPATIC ENZYME 65 0.4362
2 C-REACTIVE PROTEIN 175 0.1888
3 CONGENITAL HAEMATOLOGICAL DISORDER 2 0.1818
4 GRIP STRENGTH 40 0.1747
5 VAGINAL FLATULENCE 52 0.1716
6 OPTIC NERVE OPERATION 4 0.1600
7 SWOLLEN JOINT COUNT 35 0.1400
8 FACET JOINT SYNDROME 440 0.1350
9 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, MIXED TYPE 3 0.1304
10 DEEP VEIN THROMBOSIS POSTOPERATIVE 244 0.1218
11 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, HYPERSOMNIA TYPE 12 0.1143
12 TENDER JOINT COUNT 8 0.0952
13 SWOLLEN JOINT COUNT INCREASED 299 0.0937
14 SUBCUTANEOUS DRUG ABSORPTION IMPAIRED 50 0.0891
15 LUPUS VULGARIS 105 0.0833
16 RHEUMATIC FEVER 369 0.0827
17 PERIPHERAL VENOUS DISEASE 291 0.0712
18 DUODENAL ULCER PERFORATION 528 0.0709
19 RETINITIS 120 0.0694
20 X-RAY ABNORMAL 116 0.0648
21 PORPHYRIA ACUTE 87 0.0606
22 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 430 0.0600
23 EXANTHEMA SUBITUM 2 0.0588
24 ACQUIRED PORPHYRIA 4 0.0563
25 AVOIDANT PERSONALITY DISORDER 3 0.0556
26 RHEUMATOID FACTOR POSITIVE 314 0.0543
27 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 317 0.0488
28 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 101 0.0487
29 DISLOCATION OF VERTEBRA 107 0.0469
30 HELICOBACTER INFECTION 478 0.0465
31 FOLLICULITIS 478 0.0455
32 MUSCLE INJURY 370 0.0446
33 BREAST CANCER STAGE III 289 0.0446
34 TOPICAL STEROID WITHDRAWAL REACTION 17 0.0437
35 LIP DRY 390 0.0429
36 HYPOCHOLESTEROLAEMIA 14 0.0397
37 HAND DEFORMITY 518 0.0395
38 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY 24 0.0359
39 FEMALE GENITAL TRACT FISTULA 59 0.0345
40 PEMPHIGUS 429 0.0343
41 C-REACTIVE PROTEIN ABNORMAL 220 0.0343
42 BENZODIAZEPINE DRUG LEVEL 1 0.0333
43 BLEPHAROSPASM 203 0.0322
44 HUMAN BOCAVIRUS INFECTION 6 0.0317
45 BLOOD CHOLESTEROL 14 0.0295
46 EYE LUXATION 1 0.0294
47 DRUG TOLERANCE DECREASED 81 0.0288
48 JOINT RANGE OF MOTION DECREASED 372 0.0277
49 BURSITIS 321 0.0264
50 HYPERCHOLESTEROLAEMIA 253 0.0262
51 SYNOVITIS 471 0.0261
52 BONE EROSION 92 0.0260
53 PERINEAL INFECTION 5 0.0253
54 BLOOD SMEAR TEST ABNORMAL 2 0.0250
55 PERICARDITIS 418 0.0249
56 WOUND INFECTION 262 0.0239
57 SCROTAL INFECTION 5 0.0238
58 GLOSSODYNIA 529 0.0236
59 AUTOIMMUNE CHOLANGITIS 1 0.0227
60 BASE EXCESS INCREASED 2 0.0225
61 AUTOIMMUNE DISORDER 217 0.0222
62 ONYCHOMADESIS 93 0.0221
63 RADICULOPATHY 58 0.0220
64 GRIP STRENGTH DECREASED 192 0.0218
65 BRAIN STEM AUDITORY EVOKED RESPONSE ABNORMAL 1 0.0213
66 IRRITABLE BOWEL SYNDROME 455 0.0212
67 MATERNAL EXPOSURE TIMING UNSPECIFIED 79 0.0210
68 NAIL DISORDER 176 0.0201
69 OVERLAP SYNDROME 13 0.0186
70 PROCTITIS 52 0.0185
71 FIBROMYALGIA 450 0.0185
72 SCIATICA 285 0.0179
73 HYSTEROSALPINGO-OOPHORECTOMY 2 0.0179
74 CYSTITIS BACTERIAL 6 0.0178
75 WOUND 487 0.0174
76 LIVE BIRTH 145 0.0173
77 OBESITY 275 0.0172
78 VASCULAR ACCESS SITE PAIN 2 0.0167
79 EXOSTOSIS 146 0.0160
80 LIVER INJURY 380 0.0155
81 PUSTULAR PSORIASIS 50 0.0145
82 SYSTEMIC LUPUS ERYTHEMATOSUS 516 0.0145
83 SIDEROBLASTIC ANAEMIA 2 0.0143
84 IMPAIRED HEALING 469 0.0143
85 BLADDER TRANSITIONAL CELL CARCINOMA 20 0.0140
86 LUPUS-LIKE SYNDROME 126 0.0139
87 INFECTED DERMAL CYST 5 0.0139
88 ONYCHOMYCOSIS 58 0.0132
89 SERONEGATIVE ARTHRITIS 15 0.0131
90 TYPE 2 DIABETES MELLITUS 441 0.0131
91 FINGER DEFORMITY 61 0.0126
92 RED BLOOD CELL SEDIMENTATION RATE INCREASED 137 0.0124
93 CHRONIC SINUSITIS 46 0.0122
94 INFUSION SITE REACTION 35 0.0117
95 PRODUCT LABEL CONFUSION 65 0.0111
96 PSORIATIC ARTHROPATHY 449 0.0111
97 ANTICIPATORY ANXIETY 3 0.0110
98 AMOEBIC COLITIS 1 0.0110
99 DEATH NEONATAL 15 0.0108
100 LOWER LIMB FRACTURE 202 0.0105
101 ANTIPHOSPHOLIPID ANTIBODIES 2 0.0103
102 ARTERIOVENOUS FISTULA 5 0.0102
103 NIGHT SWEATS 316 0.0098
104 RASH VESICULAR 47 0.0097
105 GASTRITIS FUNGAL 1 0.0097
106 PHAEOCHROMOCYTOMA CRISIS 2 0.0094
107 LOWER RESPIRATORY TRACT INFECTION 412 0.0091
108 TASTE DISORDER 181 0.0089
109 BACK INJURY 96 0.0088
110 PULMONARY FIBROSIS 169 0.0088
111 SYNOVIAL DISORDER 4 0.0088
112 JOINT DISLOCATION 92 0.0087
113 CONTRAINDICATED PRODUCT ADMINISTERED 261 0.0086
114 ASTEATOSIS 1 0.0085
115 FOOT DEFORMITY 92 0.0083
116 INFUSION RELATED REACTION 547 0.0082
117 COELIAC DISEASE 79 0.0080
118 HERPES SIMPLEX VIRAEMIA 1 0.0080
119 ARTHROPATHY 443 0.0080
120 STOMATITIS 482 0.0079
121 GAIT INABILITY 265 0.0079
122 INFLAMMATION 403 0.0078
123 BLOOD CHOLESTEROL INCREASED 357 0.0077
124 CRYPTOCOCCAL MENINGOENCEPHALITIS 1 0.0076
125 EPILEPSY 233 0.0076
126 OSTEOARTHRITIS 322 0.0076
127 CHOLANGITIS INFECTIVE 2 0.0075
128 BRAIN COMPRESSION 3 0.0075
129 STEATOHEPATITIS 4 0.0075
130 DECOMPENSATED HYPOTHYROIDISM 1 0.0074
131 HIP ARTHROPLASTY 113 0.0074
132 ROAD TRAFFIC ACCIDENT 302 0.0072
133 TENOSYNOVITIS STENOSANS 4 0.0072
134 HEPATIC ENZYME INCREASED 489 0.0072
135 ADRENAL SUPPRESSION 6 0.0071
136 BREAST CANCER STAGE II 59 0.0071
137 IMMATURE GRANULOCYTE COUNT INCREASED 2 0.0071
138 BLISTER 396 0.0070
139 LUNG DISORDER 345 0.0070
140 WALKING AID USER 46 0.0070
141 WHEEZING 405 0.0068
142 PRESCRIBED OVERDOSE 129 0.0067
143 DISCOMFORT 398 0.0065
144 LIVER DISORDER 284 0.0064
145 C-REACTIVE PROTEIN INCREASED 233 0.0064
146 HEPATIC CIRRHOSIS 120 0.0064
147 GASTROENTERITIS ADENOVIRUS 1 0.0064
148 GENERAL SYMPTOM 44 0.0059
149 MUSCULOSKELETAL PAIN 306 0.0058
150 STEROID DEPENDENCE 5 0.0057
151 THERAPEUTIC PRODUCT EFFECT DECREASED 254 0.0057
152 PRESCRIBED UNDERDOSE 113 0.0057
153 VAGINAL DISCHARGE 57 0.0056
154 HERPES ZOSTER MENINGOENCEPHALITIS 2 0.0056
155 ANTIBODY TEST ABNORMAL 4 0.0056
156 ILL-DEFINED DISORDER 328 0.0054
157 ENDOMETRIAL THICKENING 3 0.0054
158 HERPES SIMPLEX OESOPHAGITIS 1 0.0054
159 MYOSITIS 48 0.0053
160 DRY MOUTH 432 0.0053
161 SWELLING 495 0.0053
162 LIPID METABOLISM DISORDER 2 0.0052
163 MENTAL DISABILITY 3 0.0052
164 NORMAL NEWBORN 28 0.0051
165 FREQUENT BOWEL MOVEMENTS 138 0.0051
166 SKIN WEEPING 18 0.0050
167 DRUG-INDUCED LIVER INJURY 156 0.0050
168 DRUG INTOLERANCE 480 0.0050
169 BLOOD GROWTH HORMONE DECREASED 1 0.0050
170 SECONDARY IMMUNODEFICIENCY 6 0.0049
171 EYE INJURY 15 0.0049
172 STEROID WITHDRAWAL SYNDROME 5 0.0049
173 NAIL OPERATION 2 0.0048
174 MOBILITY DECREASED 345 0.0048
175 INJURY 329 0.0047
176 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 79 0.0046
177 PREGNANCY 93 0.0046
178 BRACHIAL PLEXOPATHY 1 0.0045
179 GASTROENTERITIS NOROVIRUS 6 0.0045
180 KNEE ARTHROPLASTY 95 0.0045
181 RHEUMATOID ARTHRITIS 510 0.0045
182 SLEEP DISORDER 312 0.0044
183 ADVERSE REACTION 57 0.0043
184 EAR INFECTION 114 0.0043
185 GENERAL PHYSICAL HEALTH DETERIORATION 484 0.0042
186 JOINT SWELLING 499 0.0041
187 MACULAR DEGENERATION 49 0.0041
188 MATERNAL EXPOSURE DURING PREGNANCY 359 0.0040
189 ORAL CANDIDIASIS 53 0.0040
190 THERAPY NON-RESPONDER 179 0.0040
191 ULCER HAEMORRHAGE 26 0.0038
192 UMBILICAL CORD ABNORMALITY 2 0.0038
193 MUSCULOSKELETAL STIFFNESS 332 0.0038
194 ECZEMA INFECTED 1 0.0037
195 LIVER FUNCTION TEST INCREASED 79 0.0037
196 ANTITHROMBIN III DECREASED 1 0.0037
197 HYPERADRENOCORTICISM 1 0.0036
198 ENTEROBACTER INFECTION 6 0.0036
199 DAIRY INTOLERANCE 1 0.0036
200 JOINT STIFFNESS 93 0.0035
201 DISABILITY 70 0.0035
202 GASTROINTESTINAL DISORDER 316 0.0035
203 COLITIS ULCERATIVE 157 0.0035
204 OEDEMA 186 0.0034
205 WEIGHT FLUCTUATION 35 0.0033
206 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 57 0.0033
207 EAR INFECTION FUNGAL 1 0.0033
208 RESPIRATORY DISORDER 99 0.0033
209 BLADDER TAMPONADE 1 0.0033
210 TREATMENT FAILURE 272 0.0033
211 FIBROMA 3 0.0033
212 HUMAN HERPESVIRUS 6 INFECTION 6 0.0032
213 INTENTIONAL PRODUCT USE ISSUE 278 0.0032
214 PERIORAL DERMATITIS 2 0.0031
215 RECTAL HAEMORRHAGE 135 0.0031
216 PARAESTHESIA ORAL 45 0.0031
217 DELIRIUM 108 0.0031
218 SINUSITIS 315 0.0031
219 VULVAL DISORDER 2 0.0030
220 COMMINUTED FRACTURE 1 0.0030
221 CONGENITAL ANOMALY 23 0.0030
222 MIGRAINE 281 0.0029
223 GROWTH FAILURE 1 0.0029
224 EPIDURAL LIPOMATOSIS 1 0.0029
225 HYPOAESTHESIA 432 0.0029
226 EAR PAIN 56 0.0029
227 DERMAL CYST 7 0.0028
228 FOETAL HEART RATE DECELERATION ABNORMALITY 2 0.0028
229 BLOOD PRESSURE SYSTOLIC ABNORMAL 7 0.0028
230 DYSHIDROTIC ECZEMA 2 0.0028
231 HYPOTHALAMIC PITUITARY ADRENAL AXIS SUPPRESSION 1 0.0028
232 HEPATITIS 71 0.0028
233 GLOMERULONEPHRITIS PROLIFERATIVE 1 0.0028
234 CLAUSTROPHOBIA 3 0.0027
235 BLOOD PRESSURE DIASTOLIC ABNORMAL 7 0.0027
236 APPLICATION SITE PUSTULES 1 0.0027
237 ABDOMINAL DISCOMFORT 459 0.0027
238 BODY TEMPERATURE ABNORMAL 5 0.0027
239 AXILLARY VEIN THROMBOSIS 1 0.0027
240 HEPATIC INFARCTION 1 0.0027
241 DYSPEPSIA 261 0.0027
242 ADENOIDAL HYPERTROPHY 1 0.0026
243 URTICARIA 442 0.0026
244 BLOODY DISCHARGE 3 0.0026
245 ADENOIDECTOMY 1 0.0026
246 JOINT DESTRUCTION 4 0.0026
247 ADRENOCORTICAL INSUFFICIENCY ACUTE 5 0.0026
248 CEREBELLAR STROKE 1 0.0026
249 MEDICATION ERROR 141 0.0025
250 SCLERITIS 4 0.0025
251 PNEUMATOSIS INTESTINALIS 7 0.0025
252 SUSPECTED OFF LABEL USE 11 0.0024
253 ERYTHRODERMIC PSORIASIS 2 0.0024
254 EXPOSURE DURING PREGNANCY 150 0.0024
255 OSTEOPOROSIS 99 0.0024
256 ALOPECIA 471 0.0024
257 CONFUSIONAL STATE 385 0.0024
258 WHITE MATTER LESION 3 0.0024
259 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 167 0.0023
260 WHITE BLOOD CELL COUNT INCREASED 90 0.0023
261 BACK DISORDER 38 0.0023
262 CORONA VIRUS INFECTION 1 0.0023
263 CONTUSION 223 0.0023
264 INFECTION 334 0.0023
265 HYPERSENSITIVITY 424 0.0023
266 MUSCLE SPASTICITY 28 0.0023
267 FEEDING INTOLERANCE 1 0.0022
268 GENERAL ANAESTHESIA 1 0.0022
269 ALLERGY TEST POSITIVE 1 0.0022
270 SPONDYLITIS 8 0.0022
271 AGORAPHOBIA 3 0.0022
272 LABORATORY TEST ABNORMAL 64 0.0022
273 PERIPHERAL SWELLING 334 0.0022
274 HYPERTENSION 458 0.0022
275 ECZEMA HERPETICUM 1 0.0022
276 GASTRIC VARICES 1 0.0021
277 FEBRILE BONE MARROW APLASIA 9 0.0021
278 WEIGHT INCREASED 471 0.0021
279 HELPLESSNESS 1 0.0021
280 DIABETES INSIPIDUS 5 0.0021
281 GASTROOESOPHAGEAL REFLUX DISEASE 166 0.0021
282 BLOOD CORTICOTROPHIN DECREASED 1 0.0020
283 ECZEMA NUMMULAR 1 0.0020
284 NASOPHARYNGITIS 376 0.0020
285 VENOUS THROMBOSIS 8 0.0020
286 HYPOFIBRINOGENAEMIA 2 0.0020
287 PARAESTHESIA 313 0.0020
288 SECONDARY ADRENOCORTICAL INSUFFICIENCY 3 0.0020
289 MEMORY IMPAIRMENT 273 0.0020
290 DRUG TOLERANCE 10 0.0020
291 THERAPEUTIC PRODUCT EFFECT DELAYED 9 0.0020
292 ASPARTATE AMINOTRANSFERASE ABNORMAL 3 0.0020
293 APPLICATION SITE INFECTION 1 0.0020
294 PANCREATITIS 101 0.0019
295 STRONGYLOIDIASIS 3 0.0019
296 ASTHMA 208 0.0018
297 SKIN WRINKLING 5 0.0018
298 GASTROENTERITIS ESCHERICHIA COLI 1 0.0018
299 HAEMORRHAGIC INFARCTION 1 0.0018
300 UNMASKING OF PREVIOUSLY UNIDENTIFIED DISEASE 2 0.0018
301 ANAL HAEMORRHAGE 5 0.0018
302 APNOEIC ATTACK 1 0.0018
303 BURN ORAL CAVITY 1 0.0017
304 SPINAL FUSION SURGERY 7 0.0017
305 EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER 3 0.0017
306 DERMO-HYPODERMITIS 1 0.0017
307 CREPITATIONS 5 0.0017
308 UTERINE POLYP 3 0.0017
309 OTITIS EXTERNA 2 0.0016
310 STAPHYLOCOCCAL SKIN INFECTION 2 0.0016
311 MUSCULAR WEAKNESS 184 0.0016
312 MUSCLE SPASMS 295 0.0016
313 ALLERGY TO CHEMICALS 2 0.0016
314 DERMATOSIS 1 0.0016
315 HEPATOBILIARY DISEASE 1 0.0016
316 ERYSIPELAS 8 0.0016
317 BACILLUS INFECTION 1 0.0016
318 AMNESIA 103 0.0016
319 MENOMETRORRHAGIA 3 0.0016
320 CHOLINERGIC SYNDROME 1 0.0016
321 ANOXIC ENCEPHALOPATHY 1 0.0016
322 ABDOMINAL WALL ABSCESS 1 0.0015
323 RHINOVIRUS INFECTION 6 0.0015
324 ABDOMINAL PAIN UPPER 317 0.0015
325 ANTINUCLEAR ANTIBODY POSITIVE 5 0.0015
326 DEVICE BATTERY ISSUE 1 0.0015
327 FEELING HOT 93 0.0015
328 GINGIVAL DISCOMFORT 1 0.0015
329 HYPOVITAMINOSIS 2 0.0015
330 ADVERSE EVENT 138 0.0015
331 INTRACRANIAL ANEURYSM 6 0.0015
332 NECK PAIN 82 0.0015
333 LIMB OPERATION 7 0.0015
334 RHEUMATOID NODULE 4 0.0015
335 PLEURITIC PAIN 4 0.0014
336 CUSHING'S SYNDROME 1 0.0014
337 ELECTRIC SHOCK SENSATION 4 0.0014
338 COLITIS 54 0.0014
339 DERMATITIS DIAPER 1 0.0014
340 CONDITION AGGRAVATED 422 0.0014
341 BITE 1 0.0014
342 BODY TEMPERATURE INCREASED 28 0.0014
343 PROCEDURAL PAIN 38 0.0014
344 ATROPHIC VULVOVAGINITIS 1 0.0014
345 CONJUNCTIVITIS ALLERGIC 2 0.0013
346 DISSEMINATED CRYPTOCOCCOSIS 1 0.0013
347 COMPLICATION OF PREGNANCY 1 0.0013
348 RED BLOOD CELL SEDIMENTATION RATE ABNORMAL 3 0.0013
349 CYTOMEGALOVIRUS ENTEROCOLITIS 1 0.0013
350 HYPERTROPHIC CARDIOMYOPATHY 2 0.0013
351 ENDOCARDITIS BACTERIAL 1 0.0013
352 OEDEMA PERIPHERAL 155 0.0013
353 CUSHINGOID 4 0.0012
354 LEARNING DISORDER 3 0.0012
355 RASH 538 0.0012
356 GRANULOMA SKIN 1 0.0012
357 UNDERDOSE 89 0.0012
358 INSOMNIA 322 0.0012
359 DEPRESSION 273 0.0012
360 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 57 0.0012
361 ABDOMINAL PAIN 275 0.0012
362 PYREXIA 409 0.0012
363 CORONARY ARTERY DISSECTION 1 0.0012
364 PRODUCT QUALITY ISSUE 158 0.0012
365 SERUM FERRITIN DECREASED 2 0.0012
366 ADRENAL INSUFFICIENCY 14 0.0012
367 ENDOCRINE OPHTHALMOPATHY 1 0.0012
368 TOOTH INJURY 5 0.0012
369 PROTEIN TOTAL INCREASED 3 0.0011
370 DECREASED APPETITE 260 0.0011
371 INCORRECT PRODUCT ADMINISTRATION DURATION 24 0.0011
372 PRODUCT USE IN UNAPPROVED INDICATION 273 0.0011
373 CHEST PAIN 204 0.0011
374 RHINALGIA 3 0.0011
375 ADVERSE DRUG REACTION 98 0.0011
376 PRODUCT USE ISSUE 205 0.0011
377 IMMUNE-MEDIATED MYOSITIS 3 0.0011
378 BLOOD PRESSURE DIASTOLIC DECREASED 8 0.0011
379 SYNOVIAL CYST 5 0.0011
380 PNEUMOPERITONEUM 2 0.0011
381 ADENOCARCINOMA GASTRIC 1 0.0011
382 HERPES SIMPLEX 7 0.0011
383 UMBILICAL HERNIA 5 0.0011
384 HAEMATOCHEZIA 59 0.0011
385 CROSS SENSITIVITY REACTION 1 0.0010
386 ABDOMINAL WALL HAEMATOMA 2 0.0010
387 FLUID RETENTION 52 0.0010
388 COLON ADENOMA 1 0.0010
389 ARTHRALGIA 417 0.0010
390 AUTONOMIC NEUROPATHY 1 0.0010
391 VULVOVAGINAL PRURITUS 5 0.0010
392 DERMATITIS ACNEIFORM 6 0.0010
393 DERMATITIS PSORIASIFORM 2 0.0010
394 BENIGN PROSTATIC HYPERPLASIA 5 0.0010
395 CHEST INJURY 2 0.0010
396 ARTHRITIS 75 0.0010
397 HALLUCINATIONS, MIXED 4 0.0010
398 CLOSTRIDIUM DIFFICILE COLITIS 10 0.0009
399 ENTERITIS 6 0.0009
400 ANAL FISTULA 5 0.0009
401 MALAISE 409 0.0009
402 SKIN EROSION 3 0.0009
403 INJECTION SITE REACTION 64 0.0009
404 DEREALISATION 2 0.0009
405 APPLICATION SITE SCAB 2 0.0009
406 VOMITING 431 0.0009
407 PRURITUS 351 0.0009
408 ASTHENIA 343 0.0009
409 ANXIETY DISORDER 3 0.0009
410 VISUAL IMPAIRMENT 110 0.0009
411 FUNCTIONAL GASTROINTESTINAL DISORDER 3 0.0009
412 ENTEROCOLITIS 5 0.0009
413 FOLATE DEFICIENCY 1 0.0009
414 GLUCOSE TOLERANCE IMPAIRED 5 0.0008
415 BONE MARROW TOXICITY 1 0.0008
416 GAIT DISTURBANCE 160 0.0008
417 MONOCYTE COUNT INCREASED 3 0.0008
418 SLOW SPEECH 2 0.0008
419 JUVENILE IDIOPATHIC ARTHRITIS 2 0.0008
420 CUTANEOUS T-CELL LYMPHOMA 1 0.0008
421 TENDON PAIN 6 0.0008
422 BRAIN ABSCESS 2 0.0008
423 ABDOMINAL DISTENSION 82 0.0008
424 PAIN 482 0.0008
425 ENDOCRINE DISORDER 1 0.0008
426 APPLICATION SITE EROSION 1 0.0008
427 GASTROINTESTINAL CARCINOMA 7 0.0008
428 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 2 0.0008
429 PNEUMONIA 243 0.0007
430 TACHYCARDIA 66 0.0007
431 BLOOD SODIUM INCREASED 2 0.0007
432 APPLICATION SITE DISCOLOURATION 3 0.0007
433 SLEEP APNOEA SYNDROME 14 0.0007
434 ABNORMAL FAECES 6 0.0007
435 JOINT EFFUSION 5 0.0007
436 APPLICATION SITE INFLAMMATION 1 0.0007
437 DIZZINESS 360 0.0007
438 ATTENTION DEFICIT HYPERACTIVITY DISORDER 3 0.0007
439 SKIN HYPERTROPHY 2 0.0007
440 CATAPLEXY 1 0.0007
441 WEIGHT DECREASED 197 0.0007
442 CHORIORETINOPATHY 1 0.0007
443 SKIN ATROPHY 4 0.0007
444 DEVICE DISLOCATION 30 0.0007
445 OFF LABEL USE 603 0.0007
446 FATIGUE 535 0.0007
447 HYPERTRIGLYCERIDAEMIA 4 0.0007
448 WHEELCHAIR USER 3 0.0007
449 RHINITIS ALLERGIC 3 0.0007
450 IMPETIGO 1 0.0007
451 UPPER RESPIRATORY TRACT INFECTION 31 0.0007
452 ATYPICAL PNEUMONIA 2 0.0007
453 THYROIDITIS 2 0.0007
454 PAIN IN EXTREMITY 193 0.0007
455 ANXIETY 185 0.0006
456 HEADACHE 403 0.0006
457 GASTROINTESTINAL STOMA COMPLICATION 1 0.0006
458 FUNGAEMIA 1 0.0006
459 NERVE INJURY 7 0.0006
460 SKIN INFECTION 7 0.0006
461 COSTOCHONDRITIS 1 0.0006
462 SMALL FOR DATES BABY 3 0.0006
463 HYPERNATRAEMIA 3 0.0006
464 THROMBOCYTOPENIA 67 0.0006
465 POTENTIATING DRUG INTERACTION 2 0.0006
466 CONTRAINDICATED PRODUCT PRESCRIBED 1 0.0006
467 BLOOD IRON DECREASED 7 0.0006
468 EXPOSURE TO SARS-COV-2 1 0.0006
469 FIXED ERUPTION 1 0.0006
470 GRANULOMA 2 0.0006
471 EMOTIONAL POVERTY 1 0.0006
472 BREAST DISCHARGE 1 0.0006
473 POLYARTHRITIS 3 0.0006
474 NECROTISING FASCIITIS 2 0.0006
475 HISTOPLASMOSIS 1 0.0006
476 GLOSSITIS 2 0.0006
477 PSORIASIS 73 0.0006
478 GASTROINTESTINAL INFECTION 5 0.0006
479 FOOD INTOLERANCE 2 0.0005
480 INTERMENSTRUAL BLEEDING 3 0.0005
481 ANGIOPATHY 3 0.0005
482 SNORING 2 0.0005
483 PARANASAL SINUS DISCOMFORT 2 0.0005
484 NEUROLOGICAL SYMPTOM 3 0.0005
485 DYSPNOEA 293 0.0005
486 RASH PRURITIC 28 0.0005
487 DIARRHOEA 328 0.0005
488 DRUG ERUPTION 9 0.0005
489 ALLERGIC REACTION TO EXCIPIENT 1 0.0005
490 SENSORY LOSS 4 0.0005
491 NEURALGIA 12 0.0005
492 MATERNAL EXPOSURE DURING BREAST FEEDING 2 0.0005
493 VULVOVAGINAL BURNING SENSATION 3 0.0005
494 HYPERURICAEMIA 2 0.0005
495 ANAPHYLACTOID REACTION 2 0.0005
496 APPLICATION SITE EXFOLIATION 2 0.0005
497 SOCIAL PROBLEM 2 0.0005
498 BACTERIAL INFECTION 9 0.0005
499 HOSPITALISATION 74 0.0005
500 PROCTALGIA 3 0.0005
501 BRADYPHRENIA 3 0.0005
502 ASPIRATION 5 0.0005
503 BIPOLAR I DISORDER 1 0.0005
504 PARONYCHIA 2 0.0005
505 BACTERIAL TEST POSITIVE 1 0.0004
506 ILEUS PARALYTIC 2 0.0004
507 ANAL INCONTINENCE 4 0.0004
508 BREAKTHROUGH PAIN 1 0.0004
509 HYPERTRANSAMINASAEMIA 3 0.0004
510 ROSACEA 2 0.0004
511 DEFORMITY 4 0.0004
512 DEVICE MALFUNCTION 30 0.0004
513 FLANK PAIN 4 0.0004
514 VAGINAL INFECTION 2 0.0004
515 SPUTUM DISCOLOURED 4 0.0004
516 FEAR OF INJECTION 3 0.0004
517 DRUG INEFFECTIVE 554 0.0004
518 GASTROINTESTINAL TOXICITY 2 0.0004
519 ATELECTASIS 4 0.0004
520 BLOOD IMMUNOGLOBULIN E INCREASED 1 0.0004
521 MUCOUS STOOLS 2 0.0004
522 INFLAMMATORY MARKER INCREASED 2 0.0004
523 IMMUNODEFICIENCY 6 0.0004
524 HEPATIC ENZYME ABNORMAL 2 0.0004
525 KETOACIDOSIS 3 0.0004
526 HYPERPARATHYROIDISM SECONDARY 1 0.0004
527 RESPIRATORY TRACT INFECTION 10 0.0004
528 TENDERNESS 4 0.0004
529 EXFOLIATIVE RASH 1 0.0004
530 BLOOD LACTIC ACID INCREASED 2 0.0004
531 MOOD SWINGS 12 0.0004
532 HYPERLACTACIDAEMIA 1 0.0004
533 RHINITIS 3 0.0004
534 ERYTHEMA 76 0.0004
535 NAUSEA 292 0.0004
536 GASTRIC PERFORATION 1 0.0004
537 UPPER-AIRWAY COUGH SYNDROME 3 0.0004
538 INTRACRANIAL PRESSURE INCREASED 2 0.0004
539 ATYPICAL FEMUR FRACTURE 1 0.0004
540 HEART VALVE INCOMPETENCE 1 0.0003
541 FIBULA FRACTURE 1 0.0003
542 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 19 0.0003
543 ESCHERICHIA SEPSIS 1 0.0003
544 METABOLIC DISORDER 2 0.0003
545 ECZEMA 18 0.0003
546 GASTROINTESTINAL NECROSIS 1 0.0003
547 PERIPHERAL SENSORY NEUROPATHY 2 0.0003
548 ANAEMIA 65 0.0003
549 IMMUNOSUPPRESSION 3 0.0003
550 RESPIRATORY RATE INCREASED 3 0.0003
551 HISTIOCYTOSIS HAEMATOPHAGIC 1 0.0003
552 SYMPTOM RECURRENCE 2 0.0003
553 DERMATITIS 7 0.0003
554 ATRIOVENTRICULAR BLOCK SECOND DEGREE 1 0.0003
555 DYSAESTHESIA 1 0.0003
556 PIGMENTATION DISORDER 2 0.0003
557 PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION 2 0.0003
558 BREAST CANCER STAGE I 3 0.0003
559 CONJUNCTIVITIS 6 0.0003
560 GENERALISED OEDEMA 4 0.0003
561 GASTROINTESTINAL HAEMORRHAGE 27 0.0003
562 ERYTHEMA MULTIFORME 3 0.0003
563 NASAL DRYNESS 2 0.0003
564 PHOTOPHOBIA 6 0.0003
565 DERMATITIS ALLERGIC 4 0.0003
566 EOSINOPHILIC PNEUMONIA 1 0.0003
567 FEELING JITTERY 6 0.0003
568 TREATMENT NONCOMPLIANCE 17 0.0003
569 APPLICATION SITE VESICLES 2 0.0003
570 FOETAL EXPOSURE DURING PREGNANCY 25 0.0003
571 BACTERIAL SEPSIS 1 0.0003
572 NODULE 4 0.0003
573 HYPOGAMMAGLOBULINAEMIA 2 0.0003
574 DEAFNESS NEUROSENSORY 1 0.0003
575 PNEUMOCYSTIS JIROVECII PNEUMONIA 3 0.0003
576 POST-TRAUMATIC STRESS DISORDER 2 0.0003
577 CANDIDA INFECTION 5 0.0003
578 CLOSTRIDIAL INFECTION 1 0.0003
579 B-CELL LYMPHOMA 1 0.0003
580 CONSTIPATION 64 0.0003
581 APPLICATION SITE REACTION 2 0.0003
582 BRONCHIOLITIS 1 0.0003
583 MULTIPLE ORGAN DYSFUNCTION SYNDROME 8 0.0003
584 CONJUNCTIVAL HYPERAEMIA 1 0.0003
585 PNEUMONIA ASPIRATION 7 0.0003
586 ORAL DISORDER 2 0.0003
587 AMYLASE INCREASED 1 0.0003
588 SKIN DISORDER 9 0.0003
589 HEPATOTOXICITY 6 0.0003
590 EYE PRURITUS 9 0.0003
591 BONE DENSITY ABNORMAL 1 0.0003
592 APHTHOUS ULCER 2 0.0003
593 PALLOR 7 0.0003
594 HYPOALBUMINAEMIA 2 0.0003
595 HEART RATE DECREASED 9 0.0003
596 AFFECTIVE DISORDER 2 0.0003
597 NASAL DISCOMFORT 2 0.0003
598 SKIN BURNING SENSATION 18 0.0003
599 AZOTAEMIA 1 0.0003
600 BLOOD PRESSURE FLUCTUATION 6 0.0002
601 BLEPHARITIS 1 0.0002
602 OXYGEN SATURATION DECREASED 14 0.0002
603 CYSTITIS HAEMORRHAGIC 1 0.0002
604 FUNGAL SKIN INFECTION 1 0.0002
605 NOCTURIA 3 0.0002
606 HYPERAESTHESIA 2 0.0002
607 DRUG LEVEL INCREASED 4 0.0002
608 SECOND PRIMARY MALIGNANCY 2 0.0002
609 VIRAL INFECTION 8 0.0002
610 FUNGAL INFECTION 8 0.0002
611 SECRETION DISCHARGE 3 0.0002
612 SKIN PLAQUE 2 0.0002
613 FACIAL PARALYSIS 2 0.0002
614 HEPATIC PAIN 1 0.0002
615 PSEUDOMONAS INFECTION 2 0.0002
616 ANURIA 2 0.0002
617 NO ADVERSE EVENT 42 0.0002
618 MUSCLE STRAIN 2 0.0002
619 SEPTIC SHOCK 10 0.0002
620 INTENTIONAL PRODUCT MISUSE 20 0.0002
621 BEDRIDDEN 3 0.0002
622 BLOOD CREATINE INCREASED 1 0.0002
623 GAMMA-GLUTAMYLTRANSFERASE INCREASED 5 0.0002
624 SKIN EXFOLIATION 19 0.0002
625 CYTOMEGALOVIRUS VIRAEMIA 1 0.0002
626 NERVOUS SYSTEM DISORDER 7 0.0002
627 ORAL PAIN 5 0.0002
628 SINUS CONGESTION 3 0.0002
629 HEART RATE IRREGULAR 5 0.0002
630 FALL 73 0.0002
631 PNEUMONIA BACTERIAL 2 0.0002
632 BLOOD THYROID STIMULATING HORMONE INCREASED 2 0.0002
633 HYPOKALAEMIA 10 0.0002
634 BLOOD CHOLESTEROL ABNORMAL 1 0.0002
635 SKIN REACTION 3 0.0002
636 STAPHYLOCOCCAL INFECTION 7 0.0002
637 FRACTURE 4 0.0002
638 CHRONIC LYMPHOCYTIC LEUKAEMIA 1 0.0002
639 GASTRIC ULCER 4 0.0002
640 PARALYSIS 3 0.0002
641 DERMATITIS ATOPIC 11 0.0002
642 AFFECT LABILITY 2 0.0002
643 ENTEROCOCCAL INFECTION 1 0.0002
644 SINUS BRADYCARDIA 2 0.0002
645 SKIN FISSURES 4 0.0002
646 INFLAMMATORY BOWEL DISEASE 2 0.0002
647 OVERDOSE 44 0.0002
648 HEPARIN-INDUCED THROMBOCYTOPENIA 1 0.0002
649 HYPERVOLAEMIA 1 0.0002
650 BLADDER DISORDER 2 0.0002
651 LEUKOPENIA 10 0.0002
652 FLUID INTAKE REDUCED 1 0.0002
653 DERMATITIS EXFOLIATIVE 1 0.0002
654 CORONARY ARTERY STENOSIS 1 0.0002
655 LACRIMATION INCREASED 6 0.0002
656 THERAPEUTIC RESPONSE DECREASED 12 0.0002
657 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 1 0.0002
658 TOOTH ABSCESS 2 0.0002
659 NEUTROPHIL COUNT INCREASED 2 0.0002
660 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 1 0.0002
661 BACK PAIN 45 0.0002
662 HYPERBILIRUBINAEMIA 2 0.0002
663 MENINGIOMA 3 0.0002
664 APLASTIC ANAEMIA 1 0.0002
665 APPLICATION SITE ERYTHEMA 5 0.0002
666 DRUG ADMINISTERED AT INAPPROPRIATE SITE 2 0.0002
667 SCRATCH 2 0.0002
668 BRONCHITIS 14 0.0002
669 ULCER 3 0.0002
670 EYE SWELLING 7 0.0002
671 EATING DISORDER 4 0.0002
672 COMPRESSION FRACTURE 1 0.0002
673 CHEILITIS 1 0.0002
674 SKIN LACERATION 2 0.0002
675 PNEUMONITIS 5 0.0002
676 VENTRICULAR TACHYCARDIA 3 0.0002
677 DRY EYE 9 0.0002
678 HEART RATE ABNORMAL 1 0.0002
679 HEMIPARESIS 3 0.0002
680 APPLICATION SITE PRURITUS 4 0.0002
681 DERMATITIS CONTACT 2 0.0002
682 SCAR 3 0.0002
683 RED BLOOD CELL COUNT DECREASED 5 0.0002
684 HYPERSOMNIA 5 0.0002
685 DIABETES MELLITUS 13 0.0002
686 LYMPHOCYTE COUNT DECREASED 3 0.0002
687 DECREASED INTEREST 1 0.0002
688 URINARY INCONTINENCE 5 0.0002
689 OCULAR HYPERAEMIA 8 0.0002
690 ISCHAEMIC STROKE 3 0.0002
691 CATARACT 10 0.0002
692 THIRST 3 0.0002
693 GANGRENE 1 0.0002
694 ACCIDENTAL OVERDOSE 6 0.0002
695 INJECTION SITE EXTRAVASATION 2 0.0002
696 LIMB DISCOMFORT 5 0.0002
697 PANCYTOPENIA 9 0.0002
698 MIDDLE INSOMNIA 3 0.0002
699 HYPONATRAEMIA 9 0.0002
700 ANGIOEDEMA 7 0.0002
701 MUSCULOSKELETAL DISORDER 3 0.0002
702 CARDIOVASCULAR DISORDER 4 0.0002
703 ACUTE RESPIRATORY FAILURE 3 0.0002
704 GLAUCOMA 3 0.0002
705 MOVEMENT DISORDER 5 0.0002
706 HIATUS HERNIA 2 0.0002
707 ORAL HERPES 3 0.0002
708 PLATELET COUNT INCREASED 2 0.0002
709 ASPERGILLUS INFECTION 1 0.0002
710 IMMUNE SYSTEM DISORDER 2 0.0002
711 CARDIAC FAILURE ACUTE 1 0.0001
712 BLOOD BILIRUBIN INCREASED 4 0.0001
713 PRODUCT TASTE ABNORMAL 2 0.0001
714 NEUTROPHIL COUNT DECREASED 6 0.0001
715 NEUROPATHY PERIPHERAL 14 0.0001
716 CROHN'S DISEASE 1 0.0001
717 APPLICATION SITE RASH 2 0.0001
718 HYPOMAGNESAEMIA 2 0.0001
719 HUNGER 2 0.0001
720 DUODENAL ULCER 1 0.0001
721 LYMPHOPENIA 2 0.0001
722 HAND FRACTURE 1 0.0001
723 HEPATOCELLULAR INJURY 2 0.0001
724 PLATELET COUNT DECREASED 15 0.0001
725 DIVERTICULUM 1 0.0001
726 RETCHING 3 0.0001
727 IMPAIRED WORK ABILITY 3 0.0001
728 GRAFT VERSUS HOST DISEASE 1 0.0001
729 DEEP VEIN THROMBOSIS 9 0.0001
730 SWELLING FACE 9 0.0001
731 PANIC ATTACK 5 0.0001
732 GASTROENTERITIS 2 0.0001
733 SKIN HAEMORRHAGE 2 0.0001
734 RASH MACULO-PAPULAR 3 0.0001
735 NEOPLASM MALIGNANT 9 0.0001
736 BREAST TENDERNESS 1 0.0001
737 APHASIA 4 0.0001
738 HAEMODYNAMIC INSTABILITY 1 0.0001
739 BRONCHOPULMONARY ASPERGILLOSIS 1 0.0001
740 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 1 0.0001
741 LUNG INFECTION 2 0.0001
742 BRAIN FOG 2 0.0001
743 FURUNCLE 1 0.0001
744 RESPIRATORY TRACT CONGESTION 2 0.0001
745 PRODUCTIVE COUGH 6 0.0001
746 HYPOGLYCAEMIA 6 0.0001
747 BLOOD POTASSIUM INCREASED 2 0.0001
748 HICCUPS 1 0.0001
749 EYE IRRITATION 7 0.0001
750 PHOTOSENSITIVITY REACTION 2 0.0001
751 FEBRILE NEUTROPENIA 8 0.0001
752 EMBOLISM 1 0.0001
753 HEMIPLEGIA 1 0.0001
754 CELLULITIS 6 0.0001
755 GASTRIC CANCER 3 0.0001
756 BREAST CANCER 11 0.0001
757 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 3 0.0001
758 GASTRIC DISORDER 4 0.0001
759 SKIN ULCER 3 0.0001
760 MULTI-ORGAN FAILURE 2 0.0001
761 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 6 0.0001
762 ORTHOSTATIC HYPOTENSION 2 0.0001
763 EOSINOPHILIA 2 0.0001
764 BURNING SENSATION 8 0.0001
765 LYMPHADENOPATHY 4 0.0001
766 ELECTROCARDIOGRAM QT PROLONGED 4 0.0001
767 HEAVY MENSTRUAL BLEEDING 1 0.0001
768 GASTROENTERITIS VIRAL 2 0.0001
769 RESTLESS LEGS SYNDROME 2 0.0001
770 BONE DISORDER 2 0.0001
771 HYPOTENSION 22 0.0001
772 END STAGE RENAL DISEASE 2 0.0001
773 SKIN LESION 3 0.0001
774 RESPIRATORY DISTRESS 3 0.0001
775 FEELING COLD 3 0.0001
776 APPENDICITIS 1 0.0001
777 EYE PAIN 6 0.0001
778 PAIN IN JAW 3 0.0001
779 HYPOCALCAEMIA 2 0.0001
780 ANGINA PECTORIS 3 0.0001
781 INCREASED APPETITE 2 0.0001
782 BLOOD PRESSURE SYSTOLIC INCREASED 2 0.0001
783 WHITE BLOOD CELL COUNT DECREASED 11 0.0001
784 HOSPICE CARE 1 0.0001
785 EMPHYSEMA 1 0.0001
786 HYPOTHERMIA 1 0.0001
787 BONE MARROW FAILURE 2 0.0001
788 EUPHORIC MOOD 1 0.0001
789 EYE DISCHARGE 1 0.0001
790 WITHDRAWAL SYNDROME 4 0.0001
791 HYPOTHYROIDISM 3 0.0001
792 METABOLIC ACIDOSIS 3 0.0001
793 DISTURBANCE IN ATTENTION 5 0.0001
794 VAGINAL HAEMORRHAGE 4 0.0001
795 BIPOLAR DISORDER 1 0.0001
796 CLOSTRIDIUM DIFFICILE INFECTION 2 0.0001
797 MELAENA 2 0.0001
798 APPLICATION SITE PAIN 2 0.0001
799 ANAPHYLACTIC REACTION 5 0.0001
800 TRANSAMINASES INCREASED 2 0.0001
801 HYPERTENSIVE CRISIS 1 0.0001
802 INFLUENZA 10 0.0001
803 RASH PAPULAR 2 0.0001
804 THERAPEUTIC RESPONSE UNEXPECTED 4 0.0001
805 PANCREATITIS ACUTE 2 0.0001
806 CHEST DISCOMFORT 9 0.0001
807 CHOLECYSTECTOMY 1 0.0001
808 SUICIDAL IDEATION 8 0.0001
809 TINNITUS 4 0.0001
810 HERPES ZOSTER 5 0.0001
811 SHOCK 2 0.0001
812 PERICARDIAL EFFUSION 2 0.0001
813 NEOPLASM PROGRESSION 3 0.0001
814 NASAL CONGESTION 5 0.0001
815 DEATH 73 0.0001
816 COVID-19 PNEUMONIA 1 0.0001
817 BACTERAEMIA 1 0.0001
818 CHOLECYSTITIS 1 0.0001
819 HYPERLIPIDAEMIA 1 0.0001
820 DIABETIC KETOACIDOSIS 2 0.0001
821 HEPATITIS C 1 0.0001
822 LOCALISED INFECTION 2 0.0001
823 INTERSTITIAL LUNG DISEASE 4 0.0001
824 DRY SKIN 11 0.0001
825 CEREBRAL INFARCTION 2 0.0001
826 ALANINE AMINOTRANSFERASE INCREASED 5 0.0001
827 ILEUS 1 0.0001
828 HEPATIC FUNCTION ABNORMAL 3 0.0001
829 DYSARTHRIA 3 0.0001
830 INTESTINAL OBSTRUCTION 3 0.0001
831 GLYCOSYLATED HAEMOGLOBIN INCREASED 2 0.0001
832 ABDOMINAL PAIN LOWER 2 0.0001
833 PRODUCT COMPLAINT 2 0.0001
834 HAEMATEMESIS 2 0.0001
835 HYPOPHAGIA 2 0.0001
836 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 14 0.0001
837 HYPERHIDROSIS 10 0.0001
838 ANOREXIA 1 0.0001
839 ANAPHYLACTIC SHOCK 2 0.0001
840 RHINORRHOEA 5 0.0001
841 HAEMATOMA 2 0.0001
842 DIPLOPIA 2 0.0001
843 PALPITATIONS 9 0.0001
844 BLOOD CREATININE INCREASED 5 0.0001
845 MUCOSAL INFLAMMATION 2 0.0001
846 SPEECH DISORDER 4 0.0001
847 DEPRESSED MOOD 4 0.0001
848 THROMBOSIS 6 0.0001
849 PAIN OF SKIN 2 0.0001
850 IMPAIRED GASTRIC EMPTYING 1 0.0001
851 CARDIAC ARREST 6 0.0001
852 MENTAL STATUS CHANGES 2 0.0001
853 RHABDOMYOLYSIS 3 0.0001
854 CARPAL TUNNEL SYNDROME 1 0.0001
855 BLOOD TEST ABNORMAL 1 0.0001
856 DISSEMINATED INTRAVASCULAR COAGULATION 1 0.0001
857 BLINDNESS UNILATERAL 1 0.0001
858 FLATULENCE 4 0.0001
859 INTERNATIONAL NORMALISED RATIO INCREASED 2 0.0001
860 CARDIOGENIC SHOCK 1 0.0001
861 IMPAIRED QUALITY OF LIFE 1 0.0001
862 LETHARGY 4 0.0001
863 DRUG INTERACTION 11 0.0001
864 HYPOKINESIA 1 0.0001
865 LIVER FUNCTION TEST ABNORMAL 2 0.0001
866 DYSPHONIA 4 0.0001
867 ASCITES 2 0.0001
868 PSYCHOTIC DISORDER 2 0.0001
869 DRUG EFFECT LESS THAN EXPECTED 1 0.0001
870 PULMONARY OEDEMA 3 0.0001
871 THROAT IRRITATION 3 0.0001
872 BONE LOSS 1 0.0001
873 HEPATIC FAILURE 2 0.0001
874 BLOOD COUNT ABNORMAL 1 0.0001
875 ACUTE KIDNEY INJURY 10 0.0001
876 DEVICE RELATED INFECTION 1 0.0001
877 ACUTE MYELOID LEUKAEMIA 1 0.0001
878 BASAL CELL CARCINOMA 1 0.0001
879 BONE DENSITY DECREASED 2 0.0001
880 PULMONARY EMBOLISM 6 0.0001
881 RASH ERYTHEMATOUS 3 0.0001
882 MULTIPLE SCLEROSIS 3 0.0001
883 HIP FRACTURE 2 0.0001
884 EYE DISORDER 2 0.0001
885 GENERALISED TONIC-CLONIC SEIZURE 1 0.0001
886 THERAPEUTIC RESPONSE SHORTENED 2 0.0001
887 CYTOMEGALOVIRUS INFECTION 1 0.0001
888 COAGULOPATHY 1 0.0001
889 SYNCOPE 6 0.0001
890 CHILLS 7 0.0001
891 FACE OEDEMA 1 0.0001
892 ANGER 2 0.0001
893 NEUTROPENIA 8 0.0001
894 HAEMOGLOBIN DECREASED 6 0.0001
895 NIGHTMARE 2 0.0001
896 RASH MACULAR 2 0.0001
897 COLD SWEAT 1 0.0001
898 BLOOD TRIGLYCERIDES INCREASED 1 0.0001
899 ACUTE RESPIRATORY DISTRESS SYNDROME 1 0.0001
900 ASPARTATE AMINOTRANSFERASE INCREASED 3 0.0001
901 DRUG EFFECT INCOMPLETE 2 0.0001
902 CRYING 2 0.0001
903 HYPERGLYCAEMIA 2 0.0001
904 RESPIRATORY FAILURE 4 0.0001
905 LOSS OF CONSCIOUSNESS 7 0.0001
906 SOMNOLENCE 11 0.0001
907 SEPSIS 6 0.0001
908 COUGH 15 0.0001
909 EPISTAXIS 4 0.0001
910 MYALGIA 9 0.0001
911 URINARY TRACT INFECTION 9 0.0001
912 DYSPHAGIA 5 0.0001
913 DEHYDRATION 7 0.0001
914 ATRIAL FIBRILLATION 5 0.0001
915 HAEMORRHOIDS 1 0.0001
916 CHOKING 1 0.0001
917 ACTIVITIES OF DAILY LIVING IMPAIRED 1 0.0001
918 ABNORMAL BEHAVIOUR 2 0.0001
919 DISORIENTATION 2 0.0001
920 HAEMATOCRIT DECREASED 1 0.0001
921 IRRITABILITY 3 0.0000
922 CYTOKINE RELEASE SYNDROME 1 0.0000
923 FEEDING DISORDER 1 0.0000
924 HAEMORRHAGE 5 0.0000
925 BLOOD PRESSURE DECREASED 3 0.0000
926 SKIN IRRITATION 2 0.0000
927 NEPHROLITHIASIS 2 0.0000
928 OROPHARYNGEAL PAIN 4 0.0000
929 RENAL DISORDER 2 0.0000
930 DISEASE RECURRENCE 2 0.0000
931 EMOTIONAL DISTRESS 5 0.0000
932 ENCEPHALOPATHY 1 0.0000
933 HEART RATE INCREASED 4 0.0000
934 ACNE 3 0.0000
935 MALIGNANT NEOPLASM PROGRESSION 4 0.0000
936 THERAPY CESSATION 2 0.0000
937 DRUG RESISTANCE 1 0.0000
938 ANHEDONIA 1 0.0000
939 GASTRITIS 1 0.0000
940 BLOOD GLUCOSE INCREASED 7 0.0000
941 ABNORMAL DREAMS 1 0.0000
942 DIVERTICULITIS 1 0.0000
943 INCORRECT DRUG ADMINISTRATION DURATION 1 0.0000
944 BALANCE DISORDER 3 0.0000
945 DYSSTASIA 1 0.0000
946 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 1 0.0000
947 ACUTE MYOCARDIAL INFARCTION 1 0.0000
948 PLEURAL EFFUSION 2 0.0000
949 BLOOD PRESSURE INCREASED 5 0.0000
950 FEMUR FRACTURE 1 0.0000
951 PRODUCT DOSE OMISSION 2 0.0000
952 TREMOR 5 0.0000
953 RENAL FAILURE 4 0.0000
954 EXPIRED PRODUCT ADMINISTERED 1 0.0000
955 HYPERKALAEMIA 1 0.0000
956 HYPOXIA 1 0.0000
957 THERAPY INTERRUPTED 2 0.0000
958 INCORRECT ROUTE OF DRUG ADMINISTRATION 1 0.0000
959 DYSGEUSIA 2 0.0000
960 DYSPNOEA EXERTIONAL 1 0.0000
961 CHRONIC KIDNEY DISEASE 2 0.0000
962 SEIZURE 3 0.0000
963 FEELING ABNORMAL 6 0.0000
964 DRUG DEPENDENCE 4 0.0000
965 INFLUENZA LIKE ILLNESS 2 0.0000
966 RENAL IMPAIRMENT 2 0.0000
967 TOXICITY TO VARIOUS AGENTS 4 0.0000
968 CEREBROVASCULAR ACCIDENT 4 0.0000
969 DEVICE LEAKAGE 1 0.0000
970 INJECTION SITE PAIN 7 0.0000
971 COVID-19 4 0.0000
972 INCORRECT DOSE ADMINISTERED 5 0.0000
973 VISION BLURRED 3 0.0000
974 COMA 1 0.0000
975 FLUSHING 2 0.0000
976 ILLNESS 2 0.0000
977 BRADYCARDIA 1 0.0000
978 DRUG EFFECT DECREASED 1 0.0000
979 BONE PAIN 1 0.0000
980 DISEASE PROGRESSION 2 0.0000
981 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 3 0.0000
982 AGITATION 1 0.0000
983 CARDIAC FAILURE CONGESTIVE 1 0.0000
984 DRUG DOSE OMISSION 2 0.0000
985 DRUG ABUSE 1 0.0000
986 MYOCARDIAL INFARCTION 2 0.0000
987 DEVICE ISSUE 1 0.0000
988 ACCIDENTAL EXPOSURE TO PRODUCT 1 0.0000
989 PRODUCT DOSE OMISSION ISSUE 2 0.0000